Concinnitygenetics

Edinburgh, GB · 1 known investors

Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies. Spun out of the University of Edinburgh in 2023, it serves gene therapy developers in the biopharmaceutical industry.

AI & Machine LearningBiotechHealthtech